-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexicon Pharmaceuticals CEO Michael Exton Reports Acquisition of $49,999.4384 in Common Shares

PUBT·11/09/2026 13:14:27
Listen to the news
Lexicon Pharmaceuticals CEO Michael Exton Reports Acquisition of $49,999.4384 in Common Shares
  • Lexicon Pharmaceuticals CEO and director Michael Exton purchased 30,064 shares of Common Stock at $1.6631 per share.
  • The purchase increased his direct holdings to 328,496 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexicon Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001062822-26-000130), on November 09, 2026, and is solely responsible for the information contained therein.